The Mexico clinical trials market was valued at USD 364.56 Million in 2024 and is projected to reach USD 544.85 Million by 2034, growing at a CAGR of 4.10%. Growth is fueled by increased biotech investments, regulatory support, and improved clinical infrastructure. Explore key drivers, trends, and opportunities shaping the clinical research landscape in Mexico. https://www.expertmarketresearch.com/reports/mexico-clinical-trials-market